Keyphrases
New Drugs
90%
Prioritization Criteria
72%
Clinical Excellence
72%
National Institutes of Health
72%
Hearing Impairment
72%
New Diagnostics
72%
Future Role
72%
Childhood-onset
72%
Point-of-care Test
72%
Diagnostic Technology
72%
Retrospective Observational Study
72%
Genetic Screening
72%
Clinical Development
72%
Influenza
72%
Antiviral Drugs
72%
Sensitivity Analysis
36%
Existing Technology
36%
New Antivirals
36%
Health Care Services
32%
Healthcare Settings
29%
Clinical Trials
27%
Genomic Technologies
24%
Decision Maker
24%
Technological Frontier
18%
Technology Type
18%
Non-pharmaceutical
18%
United Kingdom
18%
Inflationary Pressures
18%
Health Technology
18%
HIV Infection
18%
Marketing Authorization
18%
Viral Infection
18%
Regulatory Approval
18%
Objective Structures
14%
Priority Criteria
14%
Time-to-result
14%
Single Component
14%
Health-related
14%
Result-oriented
14%
International Panel
14%
Healthcare
14%
International Consensus
14%
Delphi Method
14%
Health Technology Assessment
14%
Panel Discussion
14%
Consensus Process
14%
Expert Consensus
14%
Technology-based
14%
Storage Requirement
12%
Screening Pregnant Women
12%
Medicine and Dentistry
Health Care Cost
100%
Observational Study
72%
Antivirus Agent
72%
Nasopharyngeal Swab
72%
4 Iodo 2,5 Dimethoxyamphetamine
72%
Medical Technology
72%
Infection Control
72%
Genetic Screening
72%
Reverse Transcription Polymerase Chain Reaction
72%
Sensitivity and Specificity
72%
Hearing Impairment
72%
Early Diagnosis
72%
Neonatal Infant
72%
Antiviral Drug
72%
Virus
72%
Patient Referral
72%
Health Technology
72%
Health Service
72%
Clinical Trial
54%
Virus Infection
36%
Human Immunodeficiency Virus Infection
36%
Hepatitis C
18%
Translational Research
18%
Pharmacotherapy
18%
Aminoglycoside Antibiotic Agent
9%
Clinical Significance
9%
Base
9%